Pregnancy, Kidney Disease and Hypertension, Abhilash Koratala, MD (W-0013)

You can watch the video lecture using the link below. After watching the video, return to this page to take the quiz and survey for credit.

https://youtu.be/KczLleDc80o

YouTube CME Channel

Presented by
Abhilash Koratala, MD
Chief Nephrology Fellow
UF Division of Nephrology, Hypertension & Renal Transplantation

Target Audience
Physicians

Program Description
This CME activity consists of an educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is 1.5 hours.

Requirements for Successful Completion

• This CME activity consists of an educational component (audio lecture in an electronic format, which is followed by an online post-test).
• Certificates are awarded upon successful completion (80% proficiency) of the post-test.
• In order to receive credit, participants must view the presentation in its entirety.
• The University of Florida College of Medicine will report CME credit to CE Broker when applicable.
• There is no fee to participate in this CME activity or to receive CME credit.

Learning Objectives
As a result of participation in this activity, participants should be able to:

• Identify high risk pregnant population based on renal function.
• Define and describe hypertensive disorders of pregnancy.
• Choose appropriate therapy in pregnant women with kidney disease and hypertension.

Faculty Disclosure
Abhilash Koratala has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Continuing Medical Education Credit
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: March 31, 2016

Expiration Date: March 31, 2017

 

CME Course Credit Registration W-0013

• UFID
• Division
• Medical License Number*
• Name*
  First Last Degree (MD, PhD, ARNP, RN, PA, etc.)
• Address*
  Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country
• Email*
• Phone*

• Quiz

  You must score 80% in order to receive a passing grade and CME credit for the course.
• 1. Which of the following goes up during normal pregnancy?*
  • Plasma renin-aldosterone level
  • Serum uric acid
  • Serum sodium
• 2. Which of the following acid-base disorder is seen in normal pregnancy?*
  • Metabolic alkalosis
  • Respiratory alkalosis
  • Respiratory acidosis
• 3. Which of the following statements is false?*
  • Kidney volume remains unchanged during normal pregnancy
  • Number of nephrons do not increase during normal pregnancy
  • Mild hydronephrosis could be physiological in pregnancy
• 4. Which of the following statements is true?*
  • Stage 1 CKD is a risk factor for adverse pregnancy outcomes
  • Healthy kidney donors do not have high incidence of gestational hypertension compared to non-donors
  • Pre-pregnancy creatinine level of 2.7 has almost the same impact on pregnancy outcomes compared to creatinine of 1.2 mg/dL
• 5. Which of the following drugs is rated 'X' by US FDA for use in pregnancy?*
  • Tacrolimus
  • Rituximab
  • Sirolimus
• 6. Which of the following drugs is rated 'X' by US FDA for use in pregnancy?*
  • Azathioprine
  • Mycophenolate
  • Cyclosporine
• 7. Which of the following statements is true?*
  • Patient with Gitelman syndrome will have higher potassium supplement requirement during pregnancy
  • It is impossible for ESRD patients on hemodialysis to become pregnant
  • Incidence of asymptomatic bacteriuria is not increased in Pregnant patients with polycystic kidney disease
• 8. Which of the following is NOT an acceptable treatment option for asymptomatic bacteriuria in pregnancy?*
  • Fosfomycin
  • Cephalexin
  • Bactrim
• 9. Which of the following is a typical glomerular lesion seen in preeclampsis?*
  • Glomerular endotheliosis
  • Membranous nephropathy
  • Nodular glomerulosclerosis
• 10. Which of the following statements is correct?*
  • Serum uric acid level is elevated in preeclampsis compared to normal pregnant woman
  • Soluble fms-like tyrosine kinase 1 level is low in preeclamptic patients
  • Itching is the usual presenting symptom in Acute fatty liver of pregnancy

Please fill out the CME Evaluation Survey upon completion of this course.

You will receive a confirmation email with additional information approving your course credit.